Silo Pharma Stock Profit Margin
| SILO Stock | USD 1.84 0.05 2.65% |
Silo Pharma fundamentals help investors to digest information that contributes to Silo Pharma's financial success or failures. It also enables traders to predict the movement of Silo OTC Stock. The fundamental analysis module provides a way to measure Silo Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Silo Pharma otc stock.
Silo |
Silo Pharma OTC Stock Profit Margin Analysis
Silo Pharma's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Silo Pharma has a Profit Margin of 0.0%. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The profit margin for all United States stocks is 100.0% lower than that of the firm.
Silo Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Silo Pharma's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Silo Pharma could also be used in its relative valuation, which is a method of valuing Silo Pharma by comparing valuation metrics of similar companies.Silo Pharma is currently under evaluation in profit margin category among related companies.
Silo Fundamentals
| Return On Equity | -0.44 | ||||
| Return On Asset | -0.25 | ||||
| Operating Margin | (53.47) % | ||||
| Current Valuation | (2.06 M) | ||||
| Shares Outstanding | 2.84 M | ||||
| Shares Owned By Insiders | 6.34 % | ||||
| Shares Owned By Institutions | 5.60 % | ||||
| Number Of Shares Shorted | 61.39 K | ||||
| Price To Earning | 118.39 X | ||||
| Price To Book | 0.93 X | ||||
| Price To Sales | 77.69 X | ||||
| Revenue | 72.1 K | ||||
| Gross Profit | 66.26 K | ||||
| EBITDA | (3.86 M) | ||||
| Net Income | (3.63 M) | ||||
| Cash And Equivalents | 8.85 M | ||||
| Cash Per Share | 4.45 X | ||||
| Current Ratio | 33.28 X | ||||
| Book Value Per Share | 2.12 X | ||||
| Cash Flow From Operations | (3.22 M) | ||||
| Short Ratio | 0.46 X | ||||
| Earnings Per Share | (1.18) X | ||||
| Target Price | 10.0 | ||||
| Beta | 1.35 | ||||
| Market Capitalization | 5.6 M | ||||
| Total Asset | 7.75 M | ||||
| Retained Earnings | (10.87 M) | ||||
| Working Capital | 6.91 M | ||||
| Net Asset | 7.75 M |
About Silo Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Silo Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Silo Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Silo Pharma based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Silo Pharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Silo Pharma's short interest history, or implied volatility extrapolated from Silo Pharma options trading.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Silo Pharma. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Complementary Tools for Silo OTC Stock analysis
When running Silo Pharma's price analysis, check to measure Silo Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Silo Pharma is operating at the current time. Most of Silo Pharma's value examination focuses on studying past and present price action to predict the probability of Silo Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Silo Pharma's price. Additionally, you may evaluate how the addition of Silo Pharma to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |